| Moses Rodriguez, M.D. and Jim Maher Ph.D. |
DNA Aptamers for Promoting Remyelination |
US No. 9,809,823 |
Nov. 7, 2017 |
| Moses Rodriguez, M.D. |
Human IgG Antibodies, and Diagnostic and Therapeutic Uses Thereof Particularly in the Central Nervous System |
U.S. No. 9,260,612 B2 |
Feb. 16, 2016 |
| Moses Rodriguez, M.D. |
Human IgM Antibodies with the Capability of Inducing Remyelination, and Diagnostic and Therapeutic Uses Thereof Particularly in the Central Nervous System |
HK Patent No. HK1154604 |
Feb 16, 2016 |
| Moses Rodriguez, M.D. and Arthur E. Warrington Jr., Ph.D. |
Antibody-Induced Remyelination as a Treatment for Neonatal White Matter Injury |
U.S. No. 62/076,669 |
Nov. 7, 2014 |
| Moses Rodriguez, M.D. |
Human Antibodies and Specific Binding Sequences Thereof for Use in Stroke and Ischemia or Ischemic Conditions |
U.S. No. 14/395,141 |
Oct. 17, 2014 |
| Moses Rodriguez, M.D. |
Promotion of Central Nervous System Remyelination Using Human IgM Antibodies |
U.S. No. 7,807,166 |
Oct. 5, 2010 |
| Isobel A. Scarisbrick, Ph.D. |
Method of Treating Multiple Sclerosis with Anti-K6 Antibody |
U.S. No. 7,754,216 |
July 13, 2010 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies Which Promote Central Nervous System Remyelination |
Canadian No. 2,188,919 |
April 6, 2010 |
| Moses Rodriguez, M.D. |
Promotion of Central Nervous System Remyelination using Human IgM Antibodies |
U.S. No. 7,473,423 |
Jan. 6, 2009 |
| Moses Rodriguez, M.D. |
Human IgM Antibodies with the Capability of Inducing Remyelination, and Diagnostic and Therapeutic Uses Thereof, Particularly in the Central Nervous System |
Australian Patent No. 2000261978 |
Oct. 19, 2006 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies which Promote Central Nervous System Demyelination |
Japanese Patent No. 3789472 |
2006 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies which Promote Central Nervous System Remyelination |
European Patent No. 0801679 B1 |
March 9, 2005 |
| Moses Rodriguez, M.D. |
Treatment of Central Nervous System Diseases by Antibodies Against Glatiramer Acetate |
No. 6,800,285 |
Oct. 5, 2004 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies which Promote Central Nervous System Remyelination |
Korean (ROK) No. 406551 |
Oct. 28, 2003 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies which Promote Central Nervous System Remyelination |
Mexican No. 204041 |
Sept. 3, 2001 |
| Moses Rodriguez, M.D. |
Suppression of Demyelination by Interleukin-6 |
No. 5,863,529 |
Jan. 26, 1999 |
| Moses Rodriguez, M.D. |
Method of Treating Autoimmune and/or Viral Induced Diseases that are Mediated by CD8 Phenotype T Cells |
No. 5,660,828 |
Aug. 26, 1997 |
| Moses Rodriguez, M.D. |
Monoclonal Antibodies which Promote Central Nervous System Remyelination |
No. 5,591,629 |
Jan. 7, 1997 |